Joan Soriano to Pulmonary Disease, Chronic Obstructive
This is a "connection" page, showing publications Joan Soriano has written about Pulmonary Disease, Chronic Obstructive.
Connection Strength
3.393
-
Inhaled corticosteroids and pneumonia mortality in COPD patients. Eur Respir J. 2019 Sep; 54(3).
Score: 0.230
-
The evolution of COPD species; or, something is changing for good in COPD. Eur Respir J. 2019 Jun; 53(6).
Score: 0.227
-
What is early COPD and why is it important? Eur Respir J. 2018 12; 52(6).
Score: 0.218
-
A multicentre, randomized controlled trial of telehealth for the management of COPD. Respir Med. 2018 11; 144:74-81.
Score: 0.216
-
Temporal transitions in COPD severity stages within the GOLD 2017 classification system. Respir Med. 2018 09; 142:81-85.
Score: 0.213
-
Trends of testing for and diagnosis of a1-antitrypsin deficiency in the UK: more testing is needed. Eur Respir J. 2018 07; 52(1).
Score: 0.212
-
Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial. Eur Respir J. 2018 05; 51(5).
Score: 0.210
-
Combining case-finding methods for COPD in primary care: a large, two-stage design study. Int J Tuberc Lung Dis. 2018 01 01; 22(1):106-111.
Score: 0.204
-
Underdiagnosis in COPD: a battle worth fighting. Lancet Respir Med. 2017 05; 5(5):367-368.
Score: 0.194
-
An Epidemiological Overview of Chronic Obstructive Pulmonary Disease: What Can Real-Life Data Tell Us about Disease Management? COPD. 2017 Mar 15; 14(sup1):S3-S7.
Score: 0.193
-
New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD. Eur Respir J. 2019 Jun; 53(6).
Score: 0.056
-
Geographical Distribution of COPD Prevalence in the Americas. COPD. 2018 Jun-Aug; 15(4):317-325.
Score: 0.054
-
Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit. Int J Chron Obstruct Pulmon Dis. 2018; 13:2279-2288.
Score: 0.053
-
Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study. PLoS One. 2018; 13(6):e0198777.
Score: 0.053
-
Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease. BMC Med. 2018 03 02; 16(1):33.
Score: 0.052
-
Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort. Chest. 2018 08; 154(2):274-285.
Score: 0.052
-
Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018; 13:591-601.
Score: 0.052
-
Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study. Arch Bronconeumol (Engl Ed). 2018 May; 54(5):270-279.
Score: 0.051
-
Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores. BMC Med Res Methodol. 2017 12 21; 17(1):172.
Score: 0.051
-
Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique. Int J Chron Obstruct Pulmon Dis. 2018; 13:57-67.
Score: 0.051
-
Prevalence of COPD in 6 Urban Clusters in Argentina: The EPOC.AR Study. Arch Bronconeumol (Engl Ed). 2018 May; 54(5):260-269.
Score: 0.051
-
Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study. Respir Res. 2017 12 02; 18(1):200.
Score: 0.051
-
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease. J Am Med Dir Assoc. 2017 Dec 01; 18(12):1097.e11-1097.e24.
Score: 0.051
-
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD. Eur Respir J. 2017 11; 50(5).
Score: 0.051
-
A simple algorithm for the identification of clinical COPD phenotypes. Eur Respir J. 2017 11; 50(5).
Score: 0.051
-
Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir Res. 2017 08 23; 18(1):162.
Score: 0.050
-
Palliative care and prognosis in COPD: a systematic review with a validation cohort. Int J Chron Obstruct Pulmon Dis. 2017; 12:1721-1729.
Score: 0.049
-
Smoking cessation and COPD: further evidence is more necessary than ever. Eur Respir J. 2017 05; 49(5).
Score: 0.049
-
Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. Arch Bronconeumol. 2017 Jun; 53(6):324-335.
Score: 0.049
-
Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome? Eur Respir J. 2017 05; 49(5).
Score: 0.049
-
Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis. Chron Respir Dis. 2017 Nov; 14(4):360-369.
Score: 0.049
-
Overdiagnosis of COPD: precise definitions and proposals for improvement. Br J Gen Pract. 2017 04; 67(657):183-184.
Score: 0.048
-
Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study. Int J Chron Obstruct Pulmon Dis. 2017; 12:417-426.
Score: 0.048
-
Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care. COPD. 2015 Aug; 12(4):404-12.
Score: 0.043
-
Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study. Eur Respir J. 2015 Sep; 46(3):850-3.
Score: 0.042
-
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005 Dec; 60(12):992-7.
Score: 0.022